Twelve million for knowledge exchange between the US and Europe on heart failure

The scientists involved, representing six different countries, aim to increase our understanding of the mechanism that causes heart failure in order to develop a targeted treatment therapy.

The grant has been awarded by the Fondation Leducq (Leducq Foundation), which funds international, transatlantic research aimed at developing treatments for cardiovascular diseases.

‘Researchers worldwide are pooling their knowledge and experience by organising exchange programmes, sharing data and learning from the differences in research methods between European and American institutes. The ultimate aim is to develop new treatments for heart failure,’ says Marc Vos, Professor of Physiology at UMC Utrecht. Professor Vos’ department is involved in both projects. The other participants include Leon de Windt (UMC Utrecht Cardiopulmonary Unit), Edwin Cuppen (Hubrecht Institute and Utrecht University) and Albert Heck (Utrecht University).

This award also reinforces the joint initiatives on the Utrecht campus in the field of cardiovascular diseases, which is one of Utrecht University’s focus areas.

Research centres in Germany, Belgium, Switzerland, Italy, the US and the Netherlands are participating in this joint venture.

Media Contact

Peter van der Wilt alfa

More Information:

http://ww.uu.nl

All latest news from the category: Science Education

Back to home

Comments (0)

Write a comment

Newest articles

Trotting robots reveal emergence of animal gait transitions

A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…

Innovation promises to prevent power pole-top fires

Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…

Possible alternative to antibiotics produced by bacteria

Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…

Partners & Sponsors